Ciprofloxacin pharmacokinetics in burn patients.

Many drugs exhibit altered pharmacokinetic parameters in burn patients. We prospectively evaluated the pharmacokinetics of ciprofloxacin in eight burn patients with active infections. Each patient received a 400-mg dose of ciprofloxacin intravenously (i.v.) every 8 h, with each dose infused over 1 h...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Garrelts, J C, Jost, G, Kowalsky, S F, Krol, G J, Lettieri, J T
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163282/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8723457/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.5.1153
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!